Arche Investment
Overview
Arche Investment is a Seoul-based corporate venture capital firm and subsidiary of Reyon Pharmaceutical that focuses on early-stage investments in the biotechnology and pharmaceutical sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Elisigen | Apr 2019 | Series A | Co-investor |
| Neuracle Science | May 2024 | Private Placement | Co-investor |
| Cerecin | Oct 2021 | Series B | Lead |
| NeogenTC | - | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Arche Investment based?
Arche Investment is headquartered in Seoul, South Korea.
When was Arche Investment founded?
Arche Investment was founded in 2017.
How many portfolio companies does Arche Investment have?
Arche Investment has 4 portfolio companies in Caplight's dataset.
What are some companies in Arche Investment's portfolio?
Portfolio companies visible on Caplight include Elisigen, Neuracle Science, Cerecin, NeogenTC.
What was Arche Investment's most recent investment shown here?
Arche Investment's most recent investment in this portfolio sample was in Neuracle Science in 2024.
What sectors does Arche Investment focus on?
Arche Investment focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Arche Investment focus on?
Arche Investment typically invests at the Mid stage.